Literature DB >> 15848191

Histamine elevates the expression of Ets-1, a protooncogen in human melanoma cell lines through H2 receptor.

Hargita Hegyesi1, Barnabás Horváth, Eva Pállinger, Zoltán Pós, Viktor Molnár, András Falus.   

Abstract

Histamine is known to act, at least in part, as a growth factor for several cell types, and as production of this biogen amine has been found to accelerate the rate of tissue proliferation in wound repair, embryogenesis and malignant growth. Abundant experimental and clinical data suggest that histamine augments in vivo tumour cell proliferation via histamine H2 receptors (H2R). Here, we report that exogenously added histamine stimulates Ets-1 (v-ets erythroblastosis virus E26 oncogene homolog 1) synthesis in human melanoma cells. Involvement of histamine receptors in the histamine induced ets-1 expression has been also studied. Our data show that these newly recognized actions of histamine are mediated by the H2R. Modification of local protooncogen Ets-1 level is likely being involved in the regulation of melanoma growth.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15848191     DOI: 10.1016/j.febslet.2005.03.053

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  5 in total

1.  Histamine and histamine receptor regulation of gastrointestinal cancers.

Authors:  Lindsey Kennedy; Kyle Hodges; Fanyin Meng; Gianfranco Alpini; Heather Francis
Journal:  Transl Gastrointest Cancer       Date:  2012-10

Review 2.  Histamine receptors and cancer pharmacology: an update.

Authors:  Noelia A Massari; Melisa B Nicoud; Vanina A Medina
Journal:  Br J Pharmacol       Date:  2018-12-13       Impact factor: 8.739

Review 3.  Histamine receptors and cancer pharmacology.

Authors:  Vanina A Medina; Elena S Rivera
Journal:  Br J Pharmacol       Date:  2010-10       Impact factor: 8.739

4.  Histamine therapeutic efficacy in metastatic melanoma: Role of histamine H4 receptor agonists and opportunity for combination with radiation.

Authors:  Noelia A Massari; Melisa B Nicoud; Lorena Sambuco; Graciela P Cricco; Diego J Martinel Lamas; María V Herrero Ducloux; Horacio Blanco; Elena S Rivera; Vanina A Medina
Journal:  Oncotarget       Date:  2017-04-18

5.  Inhibition of histamine receptor H3 suppresses the growth and metastasis of human non-small cell lung cancer cells via inhibiting PI3K/Akt/mTOR and MEK/ERK signaling pathways and blocking EMT.

Authors:  Yan-Yan Zhao; Jing Jia; Jing-Jing Zhang; Yan-Ping Xun; Shu-Jun Xie; Jia-Feng Liang; Hong-Gang Guo; Jia-Zhen Zhu; Sheng-Lin Ma; Shi-Rong Zhang
Journal:  Acta Pharmacol Sin       Date:  2020-11-06       Impact factor: 7.169

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.